La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
agilon health Résultats passés
Passé contrôle des critères 0/6
agilon health has been growing earnings at an average annual rate of 0.7%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 42.4% per year.
Informations clés
0.7%
Taux de croissance des bénéfices
6.6%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 8.5% |
| Taux de croissance des recettes | 42.4% |
| Rendement des fonds propres | -32.0% |
| Marge nette | -4.1% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
agilon health: Interesting Business Model, But Volatile And Uncertain
Aug 16Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower
Aug 16
Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt
Jul 15The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More
Jun 06agilon health: Still Not Healthy Enough To Warrant Upside
Apr 19Is agilon health (NYSE:AGL) Using Too Much Debt?
Apr 04agilon health: High Growth But Unsustainable Economics
Nov 20agilon health: Strong Sales Growth, Lacks Remaining Value Drivers
Sep 13Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues
Jul 17agilon health: A Hold Until Margins Are Improved
Jun 30An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued
Jun 06Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?
Apr 28agilon gains after boosting Medicare membership outlook
Jan 09Is There An Opportunity With agilon health, inc.'s (NYSE:AGL) 39% Undervaluation?
Dec 19Ventilation des recettes et des dépenses
Comment agilon health gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 5,280 | -217 | 280 | 0 |
| 31 Mar 24 | 4,866 | -202 | 290 | 0 |
| 31 Dec 23 | 4,316 | -195 | 286 | 0 |
| 30 Sep 23 | 3,709 | -79 | 287 | 0 |
| 30 Jun 23 | 3,188 | -78 | 265 | 0 |
| 31 Mar 23 | 2,789 | -83 | 237 | 0 |
| 31 Dec 22 | 2,388 | -92 | 206 | 0 |
| 30 Sep 22 | 2,481 | -108 | 195 | 0 |
| 30 Jun 22 | 2,245 | -114 | 185 | 0 |
| 31 Mar 22 | 2,074 | -391 | 451 | 0 |
| 31 Dec 21 | 1,521 | -384 | 422 | 0 |
| 30 Sep 21 | 1,692 | -387 | 438 | 0 |
| 30 Jun 21 | 1,546 | -363 | 429 | 0 |
| 31 Mar 21 | 1,340 | -69 | 147 | 0 |
| 31 Dec 20 | 1,218 | -63 | 137 | 0 |
| 30 Sep 20 | 1,095 | -59 | 127 | 0 |
| 31 Dec 19 | 794 | -114 | 123 | 0 |
Des revenus de qualité: AGL is currently unprofitable.
Augmentation de la marge bénéficiaire: AGL is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: AGL is unprofitable, but has reduced losses over the past 5 years at a rate of 0.7% per year.
Accélération de la croissance: Unable to compare AGL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: AGL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6%).
Rendement des fonds propres
ROE élevé: AGL has a negative Return on Equity (-32.05%), as it is currently unprofitable.